Blocking key enzyme minimizes stroke injury

A drug that blocks the action of the enzyme Cdk5 could substantially reduce brain damage if administered shortly after a stroke, UT Southwestern Medical Center research suggests.
Source: UT Southwestern Medical Center News - Category: Hospital Management Source Type: news